Piper Sandler on Axsome Therapeutics (AXSM): 'Raising Stock PT And Remaining Bullish'
Tweet Send to a Friend
Piper Sandler analyst David Amsellem raised the price target on Axsome Therapeutics (NASDAQ: AXSM) to $223.00 (from $148.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
